跳至主要内容
临床试验/ACTRN12614000002684
ACTRN12614000002684终止2 期

In children less than 5 years old with nappy rash will topical medical grade Kanuka honey reduce nappy rash severity compared with Bepanthen Nappy Rash Ointment, and is it acceptable to parents/caregivers.

Honeylab Ltd0 个研究点目标入组 138 人开始时间: 2014年1月2日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
138

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
Years 至 4 Years(—)
性别
All

入选标准

  • Aged less than 5 years old at the time of enrolment
  • Doctor’s diagnosis of nappy rash
  • Nappy Rash Severity Score of 2 or greater

排除标准

  • Current requirement for systemic corticosteroid, systemic anti-fungal or systemic antibiotic treatment, or has had systemic corticosteroid, systemic anti-fungal or systemic antibiotic treatment within 4 weeks prior to Visit 1
  • Current requirement for topical corticosteroid, topical anti-fungal or topical antibiotic treatment for Nappy Rash
  • Known or suspected allergy to honey or Bepanthen Nappy Rash Ointment
  • Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact on the feasibility of the study or the study results

研究者

发起方
Honeylab Ltd

相似试验